Ondine Biomedical, Inc.'s total assets for Q2 2025 were C$8.79M, a decrease of -31.43% from the previous quarter. GB:OBI total liabilities were C$8.06M for the fiscal quarter, a 35.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.